[1]
“CLINICAL AND IMMUNOLOGICAL FEATURES OF OMALIZUMAB TREATMENT OF ATOPIC BRONCHIAL ASTHMA IN UZBEKISTAN”, Web med., vol. 3, no. 12, pp. 257–263, Dec. 2025, Accessed: Apr. 16, 2026. [Online]. Available: https://webofjournals.com/index.php/5/article/view/5675